Parexel expands in Ireland; WuXiPRA builds out its exec suite;

> Parexel International ($PRXL) is expanding in Ireland, taking up 30,000 square feet of space in a Dublin building formerly occupied by Amazon ($AMZN). News

> WuXi PharmaTech ($WX) and PRA ($PRAH) are staffing up their Chinese joint venture, appointing a new chief operations officer and chief medical officer. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.